Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Trovagene has formally engaged PRA Health Sciences to conduct Trovagene's Phase 1b/2 clinical trial of PCM-075, a polo-like kinase 1 inhibitor, in patients with AML.
read more
Trovagene has executed a supplier agreement with NerPharMa, to manufacture drug product for PCM-075.
read more
Wednesday, October 03, 2018
Trovagene has entered into an exclusive patent license agreement with the Massachusetts Institute of Technology (MIT).
read more
Triumvira Immunologics announced a strategic relationship with the Centre for Commercialisation of Cancer Immunotherapy (C3i).
read more
TriRx Pharmaceutical Services, LLC, a leading international CDMO, hosted Kansas Lt. Governor David Toland, Shawnee Mayor Michelle Distler, State Senator Mike Thompson, Congresswoman Jo Ella Hoye, Congresswoman Cindy Neighbor, other Shawnee city ...
read more
Tuesday, February 08, 2022
TriRx Pharmaceutical Services, LLC, a leading international CDMO, announced today that it has finalized and closed on its agreement with Elanco Animal Health Incorporated to acquire the ownership and operations of its manufacturing site in Speke, ...
read more
Triphase Accelerator and Catalent announced interim results for Triphase Accelerator's multi-center, open-label, monotherapy study of TRPH-222 in heavily pre-treated patients with relapsed and/or refractory B-cell lymphoma.
read more
Thursday, October 17, 2019
TriPharm Services is commissioning a new specialized manufacturing operation utilizing the latest isolator manufacturing equipment.
read more
Trio Pharmaceuticals and Ajinomoto Bio-Pharma Services announced a development collaboration agreement to evaluate AJICAP.
read more
Trio and Ajinomoto Bio-Pharma announced a development collaboration agreement to evaluate AJICAP for the development of TDCs.
read more
Wednesday, April 03, 2019
TriNetX announced the acquisition of Custodix NV and its InSite network, a European-based provider of services for clinical trial design, patient feasibility, and enabling workflow for patient recruitment.
read more
Trillium Health Care Products announced the appointment of three new seasoned executives -- Michael Pignatiello, Martin Quesnel, and Sherif Elkholy – and the completion of a major expansion of its liquid and semi-solid manufacturing capabilities.
read more
Wednesday, February 05, 2025
TriLink BioTechnologies has signed a non-exclusive License and Supply Agreement with Aldevron, a leading, global Contract Development and Manufacturing Organization (CDMO) providing high-quality plasmid DNA, RNA, and proteins for research, ...
read more
Trianni and Antibody Solutions jointly announced today that Antibody Solutions has entered into a license agreement with TRIANNI for use of The Trianni Mouse.
read more
TrialScope has been selected by H. Lundbeck A/S as its partner for maintaining disclosure compliance.
read more